Stay updated on HER2/EGFR Mutant Tumors Clinical Trial
Sign up to get notified when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.

Latest updates to the HER2/EGFR Mutant Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.4.2 was added to the page history, replacing the previous v3.4.1; this is a minor maintenance update that does not affect study data or core content (To avoid being alerted by small changes, set an alert condition by clicking below).SummaryDifference0.0%

- Check15 days agoChange DetectedAdded Revision: v3.4.1. Removed the funding-lapse notice and the prior Revision: v3.4.0 reference.SummaryDifference0.4%

- Check22 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH facilities' operating status was added to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check29 days agoChange DetectedThe history page now includes a glossary toggle and color-coded highlights for additions and deletions. Labels have been updated to reflect No FEAR Act Data and Revision: v3.4.0.SummaryDifference0.5%

- Check37 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedFooter now shows Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.SummaryDifference0.1%

Stay in the know with updates to HER2/EGFR Mutant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.